Market Cap : 3.04 B | Enterprise Value : 3.28 B | PE Ratio : At Loss | PB Ratio : 4.99 |
---|
NYSE:EVH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:EVH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Evolent Health has the Profitability Rank of 4.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:
1. Operating Margin %Evolent Health's Operating Margin % for the quarter that ended in Jun. 2022 was -1.20%. As of today, Evolent Health's Piotroski F-Score is 5.
For the Health Information Services subindustry, Evolent Health's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's Profitability Rank distribution charts can be found below:
* The bar in red indicates where Evolent Health's Profitability Rank falls into.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.
Evolent Health has the Profitability Rank of 4.
Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.
Profitability Rank is based on these factors:
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Evolent Health's Operating Margin % for the quarter that ended in Jun. 2022 is calculated as:
Operating Margin % | = | Operating Income (Q: Jun. 2022 ) | / | Revenue (Q: Jun. 2022 ) |
= | -3.833 | / | 319.939 | |
= | -1.20 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The zones of discrimination were as such:
Good or high score = 8 or 9
Bad or low score = 0 or 1
Evolent Health has an F-score of 5 indicating the company's financial situation is typical for a stable company.
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
Good Sign:
Evolent Health Inc operating margin is expanding. Margin expansion is usually a good sign.
4. Consistency of the profitability
5. Predictability Rank
Thank you for viewing the detailed overview of Evolent Health's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Sotunde Tunde | director | 800 N. GLEBE RD SUITE 500 ARLINGTON VA 22203 |
Keck Kim | director | 30 W. MONROE STREET, SUITE 1200 CHICAGO IL 60603 |
Barbarosh Craig A. | director | 3525 PIEDMONT RD., NE BUILDING 6, SUITE 700 ATLANTA GA 30305 |
Tutewohl Steve | officer: Chief Operating Officer | 800 NORTH GLEBE ROAD SUITE 500 ARLINGTON VA 22203 |
Shams Aammaad | officer: Controller/Prin. Acct. Officer | 800 NORTH GLEBE ROAD SUITE 500 ARLINGTON VA 22203 |
Grua Peter J | director | C/O HLM VENTURE PARTNERS 116 HUNTINGTON AVENUE, 9TH FLOOR BOSTON MA 02116 |
Johnson John Paul | officer: Chief Financial Officer | 800 NORTH GLEBE ROAD SUITE 500 ARLINGTON VA 22203 |
Unitedhealth Group Inc | director, other: Director by Deputization | 9900 BREN ROAD EAST MINNETONKA MN 55343 |
Duffy Mary Bridget | director | C/O VOCERA COMMUNICATIONS, INC. 525 RACE STREET SAN JOSE CA 95126 |
Weinberg Jonathan | officer: General Counsel | 800 N. GLEBE ROAD, SUITE 500 ARLINGTON VA 22203 |
Pomeroy Chad | officer: Chief Technology Officer | 800 N. GLEBE ROAD, SUITE 500 ARLINGTON VA 22203 |
Blackley Seth | officer: President | 800 N. GLEBE ROAD, SUITE 500 ARLINGTON VA 22203 |
Williams Frank J | director, officer: Chief Executive Officer | 800 NORTH GLEBE ROAD, SUITE 500 ARLINGTON VA 22203 |
Mcgrane Nicholas | officer: Chief Financial Officer | 800 N. GLEBE ROAD, SUITE 500 ARLINGTON VA 22203 |
Peterson Thomas Iii | officer: Chief Operating Officer | 800 N. GLEBE ROAD, SUITE 500 ARLINGTON VA 22203 |
From GuruFocus
Other Sources
By Fool 2021-09-30
By Zacks 2022-02-10
By Fool 2020-08-14
By Zacks 2020-10-06
By Seekingalpha 2022-02-23
By Zacks 2021-01-08
By Seekingalpha 2020-11-08
By Seekingalpha 2021-06-10
By Fool 2021-02-26
By Fool 2021-10-01